These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 931134)

  • 21. Infectious bovine keratoconjunctivitis: comparison of infection, signs of disease and weight gain in vaccinated versus nonvaccinated purebred Hereford heifer calves.
    Pugh GW; McDonald TJ; Kopecky KE; Kvasnicka WG
    Can J Vet Res; 1986 Apr; 50(2):259-64. PubMed ID: 3756679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity of Moraxella bovis hemolysin.
    Ostle AG; Rosenbusch RF
    Am J Vet Res; 1985 May; 46(5):1011-4. PubMed ID: 2408520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis pilin-Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine.
    Angelos JA; Bonifacio RG; Ball LM; Hess JF
    Vet Microbiol; 2007 Dec; 125(3-4):274-83. PubMed ID: 17656049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infectious bovine keratoconjunctivitis: evidence for general immunity.
    Kopecky KE; Pugh GW; McDonald TJ
    Am J Vet Res; 1983 Feb; 44(2):260-2. PubMed ID: 6830015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimentally induced infectious bovine keratoconjunctivitis: vaccination with nonviable Moraxella bovis culture.
    Hughes DE; Pugh GW
    Am J Vet Res; 1972 Dec; 33(12):2475-9. PubMed ID: 4641206
    [No Abstract]   [Full Text] [Related]  

  • 26. Detection of Moraxella bovis antibodies in infectious bovine keratoconjunctivitis by a passive hemagglutination test.
    Arora AK; Killinger AH; Myers WL
    Am J Vet Res; 1976 Dec; 37(12):1489-92. PubMed ID: 999074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized controlled field trial to assess efficacy of a Moraxella bovis pilin-cytotoxin-Moraxella bovoculi cytotoxin subunit vaccine to prevent naturally occurring infectious bovine keratoconjunctivitis.
    Angelos JA; Gohary KG; Ball LM; Hess JF
    Am J Vet Res; 2012 Oct; 73(10):1670-5. PubMed ID: 23013196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenicity and immunogenicity of piliated and nonpiliated phases of Moraxella bovis in calves.
    Jayappa HG; Lehr C
    Am J Vet Res; 1986 Oct; 47(10):2217-21. PubMed ID: 2877604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity of a Moraxella bovis bacterin containing attachment and cornea-degrading enzyme antigens.
    Gerber JD; Selzer NL; Sharpee RL; Beckenhauer WH
    Vet Immunol Immunopathol; 1988 Feb; 18(1):41-52. PubMed ID: 3376421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serologic cross-reactivity of Australian Moraxella bovis to vaccinal bacterin strains as determined by competitive ELISA.
    McConnel CS; Shum L; Gleeson BL; House JK
    Aust Vet J; 2008 Apr; 86(4):124-9. PubMed ID: 18363984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The protective efficacy of cloned Moraxella bovis pili in monovalent and multivalent vaccine formulations against experimentally induced infectious bovine keratoconjunctivitis (IBK).
    Lepper AW; Atwell JL; Lehrbach PR; Schwartzkoff CL; Egerton JR; Tennent JM
    Vet Microbiol; 1995 Jul; 45(2-3):129-38. PubMed ID: 7571364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enzyme-linked immunosorbent assay for measurement of anti-Moraxella bovis antibodies.
    Bishop B; Schurig GG; Troutt HF
    Am J Vet Res; 1982 Aug; 43(8):1443-5. PubMed ID: 7049023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of aflatoxin ingestion on the development of Moraxella bovis infectious bovine keratoconjunctivitis.
    Pugh GW; Richard JL; Kopecky KE; McDonald TJ
    Cornell Vet; 1984 Apr; 74(2):96-110. PubMed ID: 6467950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serologic response of vaccinated cattle to strains of Moraxella bovis isolated during epizootics of keratoconjunctivitis.
    Pugh GW; Hughes DE; Booth GD
    Am J Vet Res; 1978 Jan; 39(1):55-7. PubMed ID: 415645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infectious bovine keratoconjunctivitis II. Antibodies in lacrimal secretions of cattle naturally or experimentally infected with Moraxella bovis.
    Nayar PS; Saunders JR
    Can J Comp Med; 1975 Jan; 39(1):32-40. PubMed ID: 803398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of vaccination and treatment in controlling naturally occurring infectious bovine keratoconjunctivitis.
    Hughes DE; Kohlmeier RH; Pugh GW; Booth GD
    Am J Vet Res; 1979 Feb; 40(2):241-4. PubMed ID: 464360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of Moraxella bovis antibodies in the SIgA, IgG, and IgM classes of immunoglobulin in bovine lacrimal secretions by an indirect fluorescent antibody test.
    Killinger AH; Weisiger RM; Helper LC; Mansfield ME
    Am J Vet Res; 1978 Jun; 39(6):931-4. PubMed ID: 352205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Moraxella bovis pili vaccine produced by recombinant DNA technology for the prevention of infectious bovine keratoconjunctivitis.
    Lepper AW; Elleman TC; Hoyne PA; Lehrbach PR; Atwell JL; Schwartzkoff CL; Egerton JR; Tennent JM
    Vet Microbiol; 1993 Jul; 36(1-2):175-83. PubMed ID: 7901935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in titres of Moraxella bovis-specific IgG in growing cattle.
    Maidment DC; Batty DL
    Br Vet J; 1986; 142(1):65-9. PubMed ID: 3947934
    [No Abstract]   [Full Text] [Related]  

  • 40. The protective efficacy of pili from different strains of Moraxella bovis within the same serogroup against infectious bovine keratoconjunctivitis.
    Lepper AW; Moore LJ; Atwell JL; Tennent JM
    Vet Microbiol; 1992 Sep; 32(2):177-87. PubMed ID: 1359693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.